MA

Mathew Ajith

Director Director DIN 09357218
DIN 09357218 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2021
Shareholding value •••• Premium profile

About Mathew Ajith

Data last updated:

Mathew Ajith was a Director at Skinbee Healthcare Private Limited (2023–2025) and Director at Medbionix Private Limited (2021–2025). The companies operate in Healthcare.

DIN 09357218
Primary Designation Director
Industry Healthcare
First Appointment 12 Oct 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skinbee Healthcare Private Limited U86201KL2023PTC085217
Director21 Dec 20232023Active
Medbionix Private Limited U51909KL2021PTC071529
Director12 Oct 20212021₹1.70 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Skinbee Healthcare Private Limited
Medbionix Private Limited
Premium access

Shareholding and investment profile for Mathew Ajith

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mathew Ajith

Mathew Ajith was first appointed on 12 Oct 2021 as Director at Medbionix Private Limited. The most recent appointment on record is 21 Dec 2023 at Skinbee Healthcare Private Limited.

Mathew Ajith held 2 earlier board appointments: Skinbee Healthcare Private Limited (Director, 21 Dec 2023 to 08 Aug 2025); Medbionix Private Limited (Director, 12 Oct 2021 to 08 Aug 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available